|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
02.08 |
|
|
¸à¸®ÄÉÇコÄɾîÄÚ¸®¾ÆÁÖ½Äȸ»ç |
¿Ü±¹°è ÀÇ·á±â±â ¿µ¾÷»ç¿ø ¸ðÁý
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
09.26 |
|
|
(ÁÖ)¿À·¡¿Â¶óÀÌÇÁ»çÀ̾𽺠|
[¸ÞµðÄà ¿¡½ºÅ×ƽ] ÇØ¿Ü¿µ¾÷ °æ·Â ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
03.27 |
|
|
(ÁÖ)½ÎÀÌÅäÁ¨ |
¿µ¾÷º»ºÎ ÀÎÀç ¸ðÁý
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
5³â¡è |
ä¿ë½Ã |
12.04 |
|
|
Pentax Medical |
ÀÇ·á±â±â ¿µ¾÷ ½ÅÀÔ/°æ·Â ä¿ë (Á¤±ÔÁ÷)
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.05 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
03.02 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
05.04 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Regulatory Officer / Senior Regulatory O
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
05.04 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
06.03 |
|
|
µ§Ã÷ÇöóÀ̽÷γª |
[¿Ü±¹°è ÀÇ·á±â±â] RA/QA Specialist
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
05.31 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
07.21 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA II (Regional Lead Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
03.29 |
|
|
(ÁÖ)½ÎÀÌÅäÁ¨ |
½Ã½ºÅÛ»ç¾÷ºÎ ÀÎÀç ¸ðÁý
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
ÇϹݱ⠻ç¿ø¸ðÁý |
4³â¡è |
ä¿ë½Ã |
12.04 |
|
|
¸à¸®ÄÉÇコÄɾîÄÚ¸®¾ÆÁÖ½Äȸ»ç |
¿Ü±¹°è ÀÇ·á±â±â ¸¶ÄÉÆà ÆÀ¿ø (Marketing Specialist)-Á¤±Ô
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
1³â¡è |
»ó½Ãä¿ë |
10.12 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Sr. SSU Associate
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
4³â¡è |
ä¿ë½Ã |
05.04 |
|